On Wednesday October 19, The Medical Device Innovation Consortium (MDIC) announced its partnership with PerkinElmer’s Horizon Discovery to develop and manufacture somatic reference samples (SRSs) to simplify and support the validation of NGS-based cancer diagnostics.
19 result(s)
In this blog, we take a look at ClaretBio’s app note on using Horizon’s cfDNA reference standards in the development of their novel sample prep kit.
Learn how to examine your NGS data to investigate false positives and negatives, and potential downstream applications
Now Horizon's popular reference standards have been exome sequenced for higher confidence and expanded applications. Read on to find out how this new level of product information will support your diagnostics pipeline.
Horizon's new Cell free DNA formulated in synthetic matrix reference offers greater compatibility with commonly used cfDNA extraction kits.
Key steps to successfully test, and monitor patients by liquid biopsy as an alternative to solid tumor.
This article briefly describes how our reference standards are produced and the quality control measures to ensure the standards are reliable from batch to batch.
Quality control (QC) is vital for Next-generation sequencing (NGS). Here we discuss best practices that will save you time, money, and headaches.
Isolation of genomic DNA from formalin fixed paraffin embedded (FFPE) tissues is a critical step for molecular diagnostic (MDx) assays. Here we investigate extraction of DNA from FFPE using five comparable methods.
We learn of several reasons why cell line derived standards have a distinct advantage on other source materials when it comes to NGS oncology assays.